Protara Therapeutics Q1 EPS $(0.31) Beats $(0.37) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings BeatsNews
Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.37) by 16.22 percent. This is a 6.9 percent decrease over losses of $(0.29) per share
Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.37) by 16.22 percent. This is a 6.9 percent decrease over losses of $(0.29) per share from the same period last year.